Orchestra BioMed Hldgs分析师评级

2023-08-09 04:23

Orchestra BioMed Holdings, Inc.(OBIO) 0

What is the target price for Orchestra BioMed Hldgs (OBIO)?The latest price target for Orchestra BioMed Hldgs (NASDAQ: OBIO) was reported by Chardan Capital on August 9, 2023. The analyst firm set a price target for $20.00 expecting OBIO to rise to within 12 months (a possible 261.01% upside). 4 analyst firms have reported ratings in the last year.What is the most recent analyst rating for Orchestra BioMed Hldgs (OBIO)?The latest analyst rating for Orchestra BioMed Hldgs (NASDAQ: OBIO) was provided by Chardan Capital, and Orchestra BioMed Hldgs reiterated their buy rating.When is the next analyst rating going to be posted

Orchestra BioMed Hldgs分析师评级

推荐文章

美股机会日报 | 止跌企稳！纳指期货盘前涨约0.5%，有分析称美股连遭重挫后或回升；亚马逊盘前大跌超8%

一周财经日历 | 事关降息！美国1月非农、CPI数据下周公布；恒指季检结果下周五揭晓

华尔街大多头漫谈黄金“黑天鹅”风险：马斯克实现太空采金，化身全球央行行长

避险情绪席卷市场 华尔街青睐的热门交易纷纷崩跌

华盛早报 | 无一幸免！美股、金银、加密货币与原油集体崩盘；南向资金爆买250亿港元！创约半年来新高；千问APP今日启动30亿免单

亚马逊股价盘后大跌近10%，巨额资本支出引发担忧

比特币暴跌带来124亿美元巨亏 Saylor的金融实验岌岌可危

2月6日外盘头条：比特币暴跌 亚马逊预计今年资本支出将达2000亿美元 交易员料美联储将比预期更早降息

避险情绪席卷市场华尔街青睐的热门交易纷纷崩跌

2月6日外盘头条：比特币暴跌亚马逊预计今年资本支出将达2000亿美元交易员料美联储将比预期更早降息